肢端肥大症与终末期肾病高风险相关:一项队列研究
肢端肥大症组ESKD发病率为2.00/1000人年,对照组为0.46/1000人年(HR 4.35,95%CI 2.63-7.20),校正协变量后风险仍显著升高(HR 2.36,95%CI 1.36-4.12)。糖尿病和高血压是显著中介因素。
要点
- 肢端肥大症患者ESKD风险显著高于对照(校正后HR 2.36,95%CI 1.36-4.12)。
- 糖尿病和高血压是肢端肥大症与ESKD之间的显著中介因素。
- 垂体手术和生长抑素类似物未显著改变上述关联。
核心结论
- 肢端肥大症可能独立地以及通过糖尿病和高血压等中介因素与ESKD风险升高相关。
主要发现
- ESKD发病率在肢端肥大症组为2.00/1000人年,对照组为0.46/1000人年,HR 4.35(95%CI 2.63-7.20)。
- 校正协变量后,肢端肥大症组ESKD风险仍显著高于对照组,HR 2.36(95%CI 1.36-4.12)。
- 中介分析显示糖尿病和高血压是肢端肥大症与ESKD之间的显著促进因素。
- 垂体手术和生长抑素类似物未显著改变上述关联。
关键数值与推荐
- ESKD定义为5D期或5T期。
- 肢端肥大症组ESKD发病率为2.00/1000人年,对照组为0.46/1000人年。
- 未校正HR为4.35(95%CI 2.63-7.20),校正后HR为2.36(95%CI 1.36-4.12)。
临床怎么用
- 原文未提供临床实践建议。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Acromegaly is a chronic systemic disease caused by excess levels of growth hormone and insulin-like growth factor-1 and is associated with numerous complications. Significantly, there is a lack of longitudinal data on kidney complications in patients with acromegaly. As such, we investigated the risk of end-stage kidney disease (ESKD) (stage 5D, 5T) in these patients with nationwide data obtained from the National Health Information Database of the National Health Insurance Service in Republic of Korea. A retrospective cohort study was conducted of 2.187 patients with acromegaly and 10,935 age- and sex-matched (1:5) control subjects without acromegaly over a mean follow-up period of 6.51 years. The study outcomes were analyzed using Cox proportional hazards regression analysis controlling for age, sex, household income, residential area, type 2 diabetes, hypertension, dyslipidemia, urolithiasis, congestive heart failure, myocardial infarction, stroke, and atrial fibrillation. The incidence (per 1,000 person-years) ESKD was 2.00 among patients with acromegaly but only 0.46 among controls, (hazard ratio 4.35 (95% confidence interval 2.63-7.20)) implicating a significantly higher risk. After adjustment for covariates, the risk of ESKD (2.36 (1.36-4.12)) was still significantly higher in patients with acromegaly than that in controls. Among the covariates, diabetes and hypertension were significant facilitators between acromegaly and ESKD in mediation analysis. Pituitary surgery and somatostatin analogues did not significantly change these associations. Thus, acromegaly may be linked with a higher risk for ESKD both independently and through mediators such as diabetes and hypertension.
引用
- Hong S, Kim KS, Han K, et al. A cohort study found a high risk of end-stage kidney disease associated with acromegaly. Kidney Int. 2023. PMID: 37490954. doi:10.1016/j.kint.2023.06.037
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。